ABB, Kuehne + Nagel, Roche, Synthes, UBS: Swiss Equity Preview

The following is a list of companies whose shares may have unusual price changes in Zurich. Stock symbols are in parentheses after company names. Share prices are from the last close.

The Swiss Market Index (SMI) of the biggest and most actively traded companies gained 0.7 percent to 6,400.26 on April 15. The broader Swiss Performance Index climbed 0.6 percent.

ABB Ltd. (ABBN) : The world’s biggest power-grid supplier and five other companies may bid to develop a power plant in western Iraq, Deputy Electricity Minister Salam Qazaz said. The shares increased 1.1 percent to 21.78 Swiss francs.

Actelion Ltd. (ATLN) : The Allschwil, Switzerland-based company will get support from Swiss investment fund BB Biotech AG in a dispute with Elliott Advisors (UK) Ltd., which wants to replace much of Actelion’s board, the Financial Times reported. Actelion’s stock dropped 1.1 percent to 51.15 francs.

Credit Suisse Group AG (CSGN) : OAO Sberbank and Switzerland’s second-biggest bank plan to create a $1 billion private-equity fund for investments in Russia, according to the chief executive officer of Sberbank. Shares in Credit Suisse fell 0.8 percent to 39.05 francs.

Kaba Holding AG (KABN) : The security systems maker said class action lawsuits have been filed against several of its U.S. entities over a lock that can potentially be compromised with an industrial magnet, and said its earnings outlook remains unchanged. The shares declined 0.2 percent to 384.75 francs.

Kuehne + Nagel International AG (KNIN VX): The Swiss freight forwarder’s first-quarter net income rose 18 percent to 155.4 million francs ($174 million), the company reported. The shares fell 0.7 percent to 128 francs.

Nestle SA (NESN) : The maker of KitKats and Wonka chocolate said it signed an agreement to take a 60 percent stake in Chinese food company Yinlu Foods Group. Shares in Nestle gained 2.4 percent.

Roche Holding AG (ROG) : The world’s largest maker of cancer drugs won U.S. approval to expand the use of the arthritis drug Actemra, the Food and Drug Administration said. The shares added 0.5 percent to 133.50 francs.

Sulzer AG (SUN) : The Swiss engineering company bought Brazil’s C. L. Engenharia Ltda. Shares in Sulzer lost 0.9 percent.

Synthes Inc. (SYST) : The biggest maker of devices to treat bone fractures and trauma confirmed it’s holding talks about a possible merger with Johnson & Johnson (JNJ), with no certainty about any outcome or conditions of a deal, West Chester, Pennsylvania-based Synthes said in a statement today. The shares surged 6.2 percent to 138.70 francs.

UBS AG (UBSN) : Switzerland’s largest bank said two of its top investment bankers to metals and mining companies, Dieter Hoeppli and Daniel Chu, plan to leave the company. The shares lost 0.9 percent to 16.52 francs.

To contact the reporter on this story: Giles Broom in Zurich at gbroom@bloomberg.net

To contact the editor responsible for this story: Andrew Rummer at arummer@bloomberg.net

Press spacebar to pause and continue. Press esc to stop.

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.